期刊文献+

低位直肠间质瘤治疗策略分析 被引量:2

The analysis of low rectal stromal tumor treatment strategy
下载PDF
导出
摘要 目的探讨低位直肠间质瘤的临床特征及治疗方法。方法回顾性分析32例接受手术治疗的低位直肠间质瘤病人的临床资料,按手术方法分为两组。接受Dixon及Miles手术的为扩大手术组,接受内镜下切除、经肛切除,经骶切除及经会阴切除者,为局部切除组。其中扩大切除组14例,局部切除组18例,比较两组的临床特征及术后复发转移情况。结果扩大切除组的手术时间是(152. 4±46. 2)分钟,出血量是(76. 1±36. 6) ml,肛门排气时间(3. 8±0. 6)天,住院时间(10. 2±1. 6)天;局部切除组分别是(54. 1±17. 9)分钟,(41. 1±20. 3) ml,(2. 9±0. 8)天和(6. 3±1. 3)天,两组比较差异均有统计学意义(P <0. 05)。两组间手术并发症,术后局部复发及远处转移比较,差异无统计学意义(P> 0. 05)。结论低位直肠间质瘤采用局部切除联合伊马替尼治疗未增加局部复发及远处转移的风险,但手术时间,出血量,住院时间显著降低,局部切除联合伊马替尼能明显减少创伤及改善病人生活质量。 Objective To study the clinical characteristics and treatment methods of the low rectal stromal tumor. Methods The clinical and follow-up data of 32 patients with low rectal gastrointestinal stromal tumor( GIST) were analysed. Paitents with Dixon and Miles operation were called group expanded resection( 14 cases),and patients with endoscopic resection,trans-anal,trans-sacral,trans-perineum resection were called group local resection( 18 cases). Compared the two groups with clinical characteristics and postoperative recurrence or metastasis. Results Operation time of group expanded resection was( 152. 4 ± 46. 2) min,while group local resection was( 54. 1 ± 17. 9) min,the blood loss of the two group was( 76. 1 ± 36. 6) ml and( 41. 1 ± 20. 3) ml,respectively;anus exhausting time of the two group was( 3. 8 ± 0. 6) d and( 2. 9 ± 0. 8) d,respectively;hospital stay of the two group was( 10. 2 ± 1. 6) d and( 6. 3 ± 1. 3) d,respectively( all P < 0. 05). There was no significant difference such as surgical complications,local recurrence and distant metastasis between the two groups. Conclusion Low rectal stromal tumor treated by local excision and imatinib did not increase the risk of local recurrence and distant metastasis,but the operation time,blood loss,hospitalization days significantly reduced,It is a safe and effective strategy to low rectal stromal tumor.
作者 吴红学 邹力 柯东 童仕伦 WU Hongxue;ZOU Li;KE Dong(Department of the First Gastrointestinal Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,China)
出处 《临床外科杂志》 2019年第1期67-70,共4页 Journal of Clinical Surgery
关键词 直肠间质瘤 局部切除 伊马替尼 rectal stromal tumor local resection imatinib
  • 相关文献

参考文献4

二级参考文献23

  • 1Ashwin Rammohan,Jeswanth Sathyanesan,Kamalakannan Rajendran,Anbalagan Pitchaimuthu,Senthil-Kumar Perumal,UP Srinivasan,Ravi Ramasamy,Ravichandran Palaniappan,Manoharan Govindan.A gist of gastrointestinal stromal tumors: A review[J].World Journal of Gastrointestinal Oncology,2013,5(6):102-112. 被引量:28
  • 2Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal stromal tumors. Am J Clin Patho,1995 ,103 :41-47.
  • 3Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle(stromal) tumors. Am J Clin Patho, 1999,23:82-87.
  • 4Miettinen M, Lasota J. Gastrointestinal stromal tumors : definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch ,2001,438:1-12.
  • 5Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas and leiomyosarcomas in the rectum and anus: a clinicopathological immunohistochemical and molecular genetic study of 144 cases. Am J Clin Patho,2001,25
  • 6Shibata Y, Ueda T, Seki H, et al. Gastrointestinal stronal tumor of the rectum. Eur J Gastroenterol Hepatol,2001,13 :283-286.
  • 7Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. HumPathol,2002,33: 669-676.
  • 8Miettinen M, Sobin LH, Sarlomo-Rikala M. immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a referenceto CD117 (KIT). Mod Pathol, 2000,13:1134-1142.
  • 9Miettinen M, EI-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol,2002 ,33 :478-483.
  • 10Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med, 2001,344: 1052-1056.

共引文献95

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部